Clinical Trial Update: MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction

View source ↗

Summary

Update on the MAP-IDM trial investigating molecular markers of sudden death during the acute phase of myocardial infarction; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Myocardial Infarction | Status: COMPLETED